Developing, funding and conducting clinical trials in immune tolerance
Preserving beta cell function with siplizumab in new onset type 1 diabetes
DESIGNATE is currently enrolling participants
If you or your child has been diagnosed with type 1 diabetes mellitus (T1DM) in the last year and a half, you may be eligible to participate.
Learn more ›
Find a study location near you.
A clinical study of an investigational drug for Type 1 Diabetes mellitus (T1DM).